In8Bio Inc is a biotechnology company focused on developing innovative therapies for cancer treatment
The company specializes in the advancement of cell-based therapies, particularly utilizing T cell engineering to target and eliminate cancer cells. By harnessing the power of the immune system, In8Bio aims to create effective and personalized treatment options for patients with various types of malignancies. Their research and development efforts are centered around developing cutting-edge approaches that enhance the efficacy and safety of immunotherapies, contributing to the evolving landscape of cancer treatment.
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
IN8bio's nsCAR platform, INB-300. Presented at AACR 2024, new preclinical data highlights its superior selectivity in targeting leukemia cells while sparing healthy tissue. Experience a potential wider therapeutic window without compromising efficacy.
Shares of PriceSmart, Inc. (NASDAQPSMT) rose sharply in today’s pre-market trading as the company posted better-than-expected earnings for its second quarter.
